Stay updated with breaking news from Revascularization Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Penumbra, Inc. (NYSE:PEN – Get Free Report) EVP Johanna Roberts sold 600 shares of the business’s stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $249.85, for a total value of $149,910.00. Following the completion of the sale, the executive vice president now directly owns 64,837 shares […]
Integral Health Asset Management LLC increased its holdings in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 16.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 35,000 shares of the company’s stock after acquiring an additional 5,000 shares during the period. Penumbra makes […]
Integral Health Asset Management LLC raised its position in Penumbra, Inc. (NYSE:PEN – Free Report) by 16.7% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 35,000 shares of the company’s stock after acquiring an additional 5,000 shares during the period. Penumbra makes up about 2.0% of Integral […]
Arcadia Investment Management Corp MI lifted its stake in Penumbra, Inc. (NYSE:PEN – Free Report) by 131.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 312 shares of the company’s stock after buying an additional 177 shares during the period. Arcadia Investment […]
Penumbra (NYSE:PEN – Get Free Report) posted its earnings results on Tuesday. The company reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.15, Briefing.com reports. The company had revenue of $261.50 million for the quarter, compared to the consensus estimate of $253.59 million. Penumbra had a return on equity of […]